Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-14CORT144Lyon Joseph Douglas plan to sell securities of CORCEPT THERAPEUTICS INC under Form 144MEDIUM
Lyon Joseph Douglas filed Form 144 to notify SEC of plan to sell 10000 units of CORCEPT THERAPEUTICS INC securities around 2026-09-14, with aggregate market value of $1,134,423.74. The total outstanding units is 108100000.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions ...
Large CapBiotechnology
2026-09-14INBX144MANHARD KIMBERLY plan to sell securities of Inhibrx Biosciences, Inc. under Form 144MEDIUM
MANHARD KIMBERLY filed Form 144 to notify SEC of plan to sell 500 units of Inhibrx Biosciences, Inc. securities around 2026-09-14, with aggregate market value of $55,130.00. The total outstanding units is 14717660.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past ...
Small CapBiotechnology
2026-09-14MLYS144Rodman David Malcom plan to sell securities of Mineralys Therapeutics, Inc. under Form 144MEDIUM
Rodman David Malcom filed Form 144 to notify SEC of plan to sell 7709 units of Mineralys Therapeutics, Inc. securities around 2026-09-14, with aggregate market value of $216,931.26. The total outstanding units is 88406885.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions ...
Mid CapBiotechnology
2026-09-14PBYI144WILSON TROY EDWARD plan to sell securities of PUMA BIOTECHNOLOGY, INC. under Form 144MEDIUM
WILSON TROY EDWARD filed Form 144 to notify SEC of plan to sell 5000 units of PUMA BIOTECHNOLOGY, INC. securities around 2026-09-14, with aggregate market value of $45,500.00. The total outstanding units is 51620066.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Small CapBiotechnology
2026-09-14PHVS144WIM SOUVERIJNS plan to sell securities of PHARVARIS N.V. under Form 144MEDIUM
WIM SOUVERIJNS filed Form 144 to notify SEC of plan to sell 26090 units of PHARVARIS N.V. securities around 2026-09-14, with aggregate market value of $1,023,583.19. The total outstanding units is 70204506.0. The amount planned to be sold represents 0.04% of total outstanding units; ...
Mid CapBiotechnology